Patents by Inventor Hans Rammensee

Hans Rammensee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TUMOUR-ASSOCIATED PEPTIDES BINDING TO MHC-MOLECULES
    Publication number: 20080057077
    Abstract: The invention relates to a tumor-associated peptide containing an amino sequence, which is selected from the group consisting of SEQ ID NO:1 to SEQ ID NO:79 of the enclosed listing. The peptide has the ability to bind to a molecule of the human major histocompatibility complex (MHC) class-I. The invention also relates to the use of the peptides for manufacture of a medicament and for treating tumorous diseases. The invention further relates to a pharmaceutical composition, which comprises at least one of the peptides.
    Type: Application
    Filed: August 30, 2007
    Publication date: March 6, 2008
    Applicant: Immatics Biotechnologies GmbH
    Inventors: Toni Weinschenk, Hans Rammensee, Stefan Stevanovic
  • TUMOUR-ASSOCIATED PEPTIDES BINDING TO MHC-MOLECULES
    Publication number: 20080051347
    Abstract: The invention relates to a tumor-associated peptide containing an amino sequence, which is selected from the group consisting of SEQ ID NO:1 to SEQ ID NO:79 of the enclosed listing. The peptide has the ability to bind to a molecule of the human major histocompatibility complex (MHC) class-I. The invention also relates to the use of the peptides for manufacture of a medicament and for treating tumorous diseases. The invention further relates to a pharmaceutical composition, which comprises at least one of the peptides.
    Type: Application
    Filed: August 30, 2007
    Publication date: February 28, 2008
    Applicant: Immatics Biotechnologies GmbH
    Inventors: Toni Weinschenk, Hans Rammensee, Stefan Stevanovic
  • Tumor-associated peptides binding to MHC-molecules
    Publication number: 20050222390
    Abstract: The invention relates to a tumor-associated peptide containing an amino sequence, which is selected from the group consisting of SEQ ID NO:1 to SEQ ID NO:79 of the enclosed listing. The peptide has the ability to bind to a molecule of the human major histocompatibility complex (MHC) class-I. The invention also relates to the use of the peptides for manufacture of a medicament and for treating tumorous diseases. The invention further relates to a pharmaceutical composition, which comprises at least one of the peptides.
    Type: Application
    Filed: November 29, 2004
    Publication date: October 6, 2005
    Inventors: Toni Weinschenk, Hans Rammensee, Stefan Stevanovic
  • Method for identifying immunoreactive peptides
    Publication number: 20050221350
    Abstract: The invention relates to a method for identifying immunoreactive peptides. According to said method, a sample of tumorous and corresponding healthy tissue is first provided, the tumor-specific expression profile is subsequently determined and antigenic peptides are isolated from the tumorous tissue and analyzed. The respective data that has been obtained is then matched and peptides are identified on the basis of said data.
    Type: Application
    Filed: November 29, 2004
    Publication date: October 6, 2005
    Inventors: Toni Weinschenk, Hans Rammensee